Pinnacle Wealth Planning Services
NNNN icon

Pinnacle Wealth Planning Services’s Anbio Biotechnology NNNN Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio NNNN Stock Details NNNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$63 Buy
+10
New +$85 ﹤0.01% 2824

Other funds holding NNNN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Larson Financial Group
Larson Financial Group St Louis, Missouri $4.11B AUM 23.62% 1-Year Est. Return
EverSource Wealth Advisors
EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return

Pinnacle Wealth Planning Services's NNNN Position: Q3 2026 in Review

Pinnacle Wealth Planning Services opened a new position in Anbio Biotechnology (NNNN) in Q3 2026: 10 shares worth $63. The stake represents ﹤0.01% of the portfolio and ranks #2824 among its holdings.

4 funds tracked by Wall St. Rank hold NNNN as of Q3 2026.

  • Pinnacle Wealth Planning Services held 10 shares of Anbio Biotechnology worth $63 as of Q3 2026.
  • Anbio Biotechnology was a new Pinnacle Wealth Planning Services position in Q3 2026.
  • Anbio Biotechnology made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #2824 holding.
  • 4 funds tracked by Wall St. Rank held Anbio Biotechnology as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.